Devers Shannon L.'s Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Jan 23, 2026
- Accession no.
- 0000874015-26-000077
- Filed
- Jan 23, 2026
- Trade date
- Jan 22, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $323.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Devers Shannon L.CIK 0002037721 | Officer (EVP, Chief Human Resources Ofc) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Common Stock | SSaleDisposed | −3,977 | $81.34 | −$323,489.18 | 22,541 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.